https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-03-01 / J. Virol. 2005 Mar;79(5):3052-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-03-01 / J. Virol. 2005 Mar;79(5):3052-622005-03-01 00:00:002019-02-15 09:15:20Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-15 / Cancer 2005 Feb;103(4):763-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-15 / Cancer 2005 Feb;103(4):763-712005-02-15 00:00:002019-02-15 08:35:13A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / HBPD INT 2005 Feb;4(1):121-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / HBPD INT 2005 Feb;4(1):121-52005-02-01 00:00:002019-02-15 08:36:23Effects of dendritic cells transfected with full length wild-type p53 and modified by bile duct cancer lysates on immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-552005-02-01 00:00:002019-02-15 09:17:49A thermometry system for quality assurance and documentation of whole body hyperthermia procedures
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-562005-02-01 00:00:002019-02-15 08:50:24Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-92005-02-01 00:00:002020-06-23 09:39:16Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-28 / World J. Gastroenterol. 2005 Jan;11(4):557-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-28 / World J. Gastroenterol. 2005 Jan;11(4):557-602005-01-28 00:00:002019-02-15 08:37:48Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-18 / Blood 2005 May;105(9):3605-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-18 / Blood 2005 May;105(9):3605-142005-01-18 00:00:002019-02-15 08:37:46Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Methods Mol. Med. 2005;109:127-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Methods Mol. Med. 2005;109:127-362005-01-01 00:00:002019-02-15 08:51:03Dendritic cells in clinical trials for multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Vopr Onkol 2005;51(6):685-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Vopr Onkol 2005;51(6):685-82005-01-01 00:00:002019-02-15 08:53:38[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
